China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
Location status: Recruiting
NCT Number: NCT06503640
The goal of this observational study is to explore the incidence and effect on prognosis of coronary microvascular dysfunction in patients present of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) >0.80.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Beijing, Beijing Municipality, 100029, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
major adverse cardiovascular events 12 months, including cardiac death, myocardial infarction, and readmission for angina.
Contact information is provided by the study sponsor or research team.
China-Japan Friendship Hospital
Other
Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06600178
Angina Patients With Non-obstructive Coronary Artery Disease, Angina Pectoris
Charlottesville, Virginia, United States
View Trial DetailsNCT06948201
Angina Patients With Non-obstructive Coronary Artery Disease, Angina Pectoris
Charlottesville, Virginia, United States
View Trial DetailsNCT06991322
Angina Pectoris, Cardiovascular Diseases
Utrecht, Netherlands
View Trial DetailsNCT05272618
Cardiovascular Diseases, Coronary Disease
Gwangju, South Korea
View Trial Details